India, Sept. 21 -- PharmEasy-owned diagnostic chain Thyrocare Technologies has approved the sale of its entire stake in wholly owned subsidiary Nueclear Healthcare Ltd (NHL) to Trovera Healthcare for ... Read More
New Delhi, Sept. 21 -- India's push for defence indigenisation and the opening of its space sector to private players are prompting former government scientists and second-time entrepreneurs to launch... Read More
Mumbai, Sept. 21 -- The Indian rupee opened weaker on Monday, with analysts maintaining a cautious near-term outlook and warning that a sustained move above 96 against the US dollar could trigger furt... Read More
Mumbai and Bengaluru, Sept. 21 -- Last Thursday in Mumbai, the Tata Sons boardroom was tense. The much-anticipated meeting wrapped up earlier than planned, lasting only about three hours. At first, it... Read More
New Delhi, Sept. 21 -- Nothing CEO Carl Pei on Monday, September 21, announced that CMF will be spun out of Nothing and become a standalone Indian company. The new entity will be majority Indian-owned... Read More
Mumbai, Sept. 21 -- The Indian rupee appreciated 15 paise to close at 95.81 (provisional) against the US dollar on Monday as crude oil prices retreated from their elevated levels on improved global ri... Read More
Mumbai, Sept. 21 -- Benchmark stock index Sensex climbed 564 points while the Nifty rose for the fourth consecutive session on Monday, supported by cooling crude oil prices, fresh foreign fund inflows... Read More
Mumbai, Sept. 21 -- Banks will not be allowed to reclassify instruments between trading book and banking book for regulatory arbitrage with the intention of achieving lower capital requirements, accor... Read More
Mumbai, Sept. 21 -- The rupee appreciated 18 paise to close at 95.78 against the US dollar on Monday as crude oil prices retreated from their elevated levels on improved global risk sentiment amid exp... Read More
New Delhi, Sept. 21 -- After hitting a 52-week low of Rs.682 on 11 September, HDFC Bank shares have rebounded, raising questions: Is it the right time to buy the stock, or is it just a technical rebou... Read More